Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Galderma Group AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: -

Employees: -

Market Cap: $22.9B

Website: http://www.galderma.com/

Clinical Trials

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Phase 4

Completed

Conditions: Rosacea

Interventions: Drug: Metronidazole gel 1%

First Posted Date: 2007-02-19

Last Posted Date: 2022-07-29

Lead Sponsor: Galderma R&D

Target Recruit Count: 26

Registration Number: NCT00436527

Locations: 🇺🇸
Colorado Springs Research Center, Colorado Springs, Colorado, United States

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Completed

Conditions: Psoriasis

Interventions: Drug: Clobetasol Propionate, 0.05%
Drug: Clobetasol propionate, 0.05% Spray

First Posted Date: 2007-02-19

Last Posted Date: 2022-07-29

Lead Sponsor: Galderma R&D

Target Recruit Count: 2488

Registration Number: NCT00437216

Locations: 🇺🇸
DHC Dimensional HealthCare, Inc. (Clinical Research Organization), Cedar Knolls, New Jersey, United States

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Phase 4

Completed

Conditions: Psoriasis

Interventions: Drug: Clobetasol Propionate 0.05% Spray
Drug: Clobetasol Propionate 0.05% Foam

First Posted Date: 2007-02-19

Last Posted Date: 2022-07-29

Lead Sponsor: Galderma R&D

Target Recruit Count: 78

Registration Number: NCT00436540

Locations: 🇺🇸
Solano Clinical Research, Vallejo, California, United States
🇺🇸
Central Dermatology, PC, Saint Louis, Missouri, United States

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Phase 4

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: Clobetasol Propionate, 0.05%
Drug: Calcipotriene and betamethasone dipropionate ointment

First Posted Date: 2007-02-19

Last Posted Date: 2022-07-29

Lead Sponsor: Galderma R&D

Target Recruit Count: 122

Registration Number: NCT00437255

Locations: 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸
DermResearch, Inc., Austin, Texas, United States
🇺🇸
J & S Studies, Inc., Bryan, Texas, United States

and more 1 locations

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

Phase 4

Completed

Conditions: Acne

First Posted Date: 2007-02-19

Last Posted Date: 2022-07-29

Lead Sponsor: Galderma R&D

Target Recruit Count: 61

Registration Number: NCT00437151

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase 3

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Adapalene Gel, 0.1%
Drug: Benzoyl Peroxide Gel 2.5%
Drug: Gel Vehicle
Drug: Adapalene/Benzoyl Peroxide

First Posted Date: 2007-01-15

Last Posted Date: 2024-04-15

Lead Sponsor: Galderma R&D

Target Recruit Count: 1668

Registration Number: NCT00422240

Locations: 🇺🇸
Miller MD, San Antonio, Texas, United States

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase 3

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Adapalene/Benzoyl Peroxide
Drug: Topical Gel Vehicle
Drug: Adapalene
Drug: Benzoyl Peroxide

First Posted Date: 2007-01-15

Last Posted Date: 2021-02-18

Lead Sponsor: Galderma R&D

Target Recruit Count: 1670

Registration Number: NCT00421993

Locations: 🇺🇸
Medical Affliated Research Center, Huntsville, Alabama, United States
🇺🇸
Dermatology Research of Arkansas, Little Rock, Arkansas, United States
🇺🇸
Associates in research, Inc., Fresno, California, United States

and more 58 locations

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

Phase 2

Completed

Conditions: Chronic Plaque Psoriasis

Interventions: Drug: Calcitriol 3mcg/g

First Posted Date: 2007-01-09

Last Posted Date: 2021-02-18

Lead Sponsor: Galderma R&D

Target Recruit Count: 25

Registration Number: NCT00419666

Locations: 🇺🇸
Dermatology Research of Arkansas, Little Rock, Arkansas, United States
🇺🇸
Children's Hospital, Department of Pediatric and Adolescent Dermatology, San Diego, California, United States
🇺🇸
Dermatology Center For Children & Young Adults, Eagan, Minnesota, United States

and more 4 locations

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Phase 3

Completed

Conditions: Scalp Psoriasis

Interventions: Drug: Clobex® Shampoo
Drug: Clobex® Vehicle Shampoo

First Posted Date: 2006-11-17

Last Posted Date: 2023-07-11

Lead Sponsor: Galderma R&D

Target Recruit Count: 288

Registration Number: NCT00400725

Locations: 🇨🇦
centre de Recherche Dermatologique du Québec, Quebec, Canada

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Phase 3

Completed

Conditions: Actinic Keratosis

First Posted Date: 2006-03-24

Last Posted Date: 2021-02-18

Lead Sponsor: Galderma R&D

Target Recruit Count: 80

Registration Number: NCT00306800

Locations: 🇺🇸
Spencer Dermatology and Skin Surgery, Saint Petersburg, Florida, United States
🇺🇸
Laser and Skin Surgery Center, New York, New York, United States
🇺🇸
Dermatology Associates of Rochester, Rochester, New York, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy